{"id":"sparc1104-modified-dose-regimen-iii","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Due to the lack of publicly available information, the exact mechanism of action of SPARC1104 is unknown.","oneSentence":"SPARC1104 is a modified dose regimen of an undisclosed compound, details of which are not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:35:36.618Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01797185","phase":"PHASE3","title":"Safety Study of SPARC1104","status":"COMPLETED","sponsor":"Sun Pharma Advanced Research Company Limited","startDate":"2013-04-09","conditions":"Spasticity","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SPARC1104 modified dose regimen III","genericName":"SPARC1104 modified dose regimen III","companyName":"Sun Pharma Advanced Research Company Limited","companyId":"sun-pharma-advanced-research-company-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SPARC1104 is a treatment being studied for spasticity, as part of a safety study that has been completed. The exact mechanism of SPARC1104 is unknown, but it is classified as a modified starch.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}